ECS ECS Botanics Holdings Ltd
Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.01
52wk 0.00 – 0.01
Overall
60.6
Value
54.5
Growth
100.0
Health
98.4
Quality
0.0
Momentum
26.3
Dividend
—
Price
About ECS Botanics Holdings Ltd
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd was founded in 2018 and is headquartered in Subiaco, Australia.
Price analytics
Returns
| 1 day | -9.1% |
| 1 week | 0.0% |
| 1 month | -16.7% |
| 3 months | 0.0% |
| 6 months | 0.0% |
| 1 year | -28.6% |
| 3 years | -79.2% |
Risk
| Volatility (1y ann.) | 151.8% |
| Beta vs ASX 200 | 2.09 |
| Sharpe (1y) | 0.46 |
| VaR 95% (1-day) | -16.7% |
| Max drawdown (1y) | -66.7% |
| Off 1-year high | -44.4% |
Technicals
| RSI(14) | 50 |
| vs 50DMA | -12.6% |
| vs 200DMA | -8.4% |
| Trend | Golden cross |
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value
54.5
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
0
Price / Book
100
Price / Sales
100
Growth
100.0
Revenue growth (1y)
100
Revenue CAGR (3y)
—
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health
98.4
Net debt / EBITDA
100
Interest coverage (EBIT/interest)
100
Current ratio
100
Debt / Equity
94
Quality (Profitability & Cash Flow)
0.0
Return on equity
0
Return on assets
0
Operating margin
0
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income
—
No meaningful dividend — pillar excluded from the overall score.
Momentum
26.3
6-month return vs ASX 200
46
Price vs 200-day average
22
Price vs 50-day average
0
Position in 52-week range
29
Hover a row's info icon for the exact rule. Bounds and weights are configurable in the Django admin (Scoring configuration).
Score history
Key metrics
Market cap
$8.81M
P/E (trailing)
—
P/E (forward)
—
EPS (trailing)
0.00
Dividend yield
—
Payout ratio
0.0%
Beta
1.14
EV / EBITDA
24.00
Price / Book
0.39
ROE
-8.4%
Operating margin
-8.6%
Net margin
-9.1%
Total cash
$1.69M
Total debt
$6.88M
Current ratio
3.45
Debt / Equity
0.30
Free cash flow
$-1.13M
Avg volume
780,172
Latest annual results
(FY ending 30 Jun 2024)
- Revenue$20.03M
- Gross profit$9.13M
- Operating income$1.74M
- Net income$1.99M
- Diluted EPS0.00
- Free cash flow-$3.88M
- Net debt-$2.13M